In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)


Class-Action Tracker

Zantac Heartburn Medication

Class Action

Zantac Heartburn Medication

In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…


The Latest

Filters

LegXercise Pro

Ad Alert

LegXercise Pro

Device maker does not have the clinical proof to back up its clinically proven claims.

Crypto.com

Ad Alert

Crypto.com

Ad regulator bans Facebook ad for failing to disclose risks of investing in NFTs.


Show More